On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
We have now added a new section called the "Assay History List" to the "At A Gla...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...